$IGPK Mega DD - Integrated Cannabis Solutions,

New Post Public Reply Private Reply Replies (0) Message Board
Compensated Post
pennybuster
$IGPK Mega DD - Integrated Cannabis Solutions, Inc.




IGPK Company Description
Integrated Cannabis Solutions, Inc. is focused on offering its suite of services geared towards reducing the risk, cost and complexity for responsible cannabis businesses during this monumental process of transitioning from prohibition to regulation.

ICS helps guide clients during their initial launch, or throughout their continued growth. The Company provides consulting on compliance, operations, and business management, as well as the branding and marketing of the business. ICS simplifies regulatory requirements and provides training to help develop responsible staff members to understand and comply with developing medical cannabis commerce. Clients will become familiar with medical cannabis laws and Marijuana Enforcement Division (MED) regulations. A major factor of any strong compliance program is the ability to foresee, and then control changes affecting costs and overall risk within the industry.

Integrated Cannabis Solutions, Inc.’s is also currently seeking to acquire initial properties that are well suited for marijuana establishment owners. The Company is heavily pursuing the acquisition of multiple commercial properties. Because of the Company’s industry knowledge and experience, these properties can be filled with relative ease. Owners of dispensaries and recreational stores are looking for more grow space, either to serve their own customers or to sell wholesale to other undersupplied merchants. The Denver Post reports owners are paying over $17 and $18 per square foot, with current quotes going even higher (that’s 4 times the price of commercial space not suited for marijuana establishments). With its knowledge and contacts the Company is positioned to be a dominant player in the recreational marijuana industry in Colorado.

IGPK Products and Services
Services to help navigate the changing cannabis industry

ICS suite of services is geared towards reducing the risk, cost and complexity for responsible cannabis businesses.


Medical and Retail Marijuana Services
ICS’s suite of services helps you navigate the challenges of regulated cannabis commerce by reducing the risk, cost, and complexity for responsible cannabis vendors in the process of transitioning from prohibition to regulation. ICS has developed a suite of compliance solutions that include manuals, inspections, and business assessments. However, we know that no business is one-size-fits-all. After assessing your business we assemble the right services and deliver results at a manageable price. All clients will save money on legal fees and turnover costs, reduce risk of charges and fines, and increase productivity by managing time more efficiently.

We help guide clients during their initial launch, or throughout their continued growth. ICS provides consulting on compliance, operations, and business management, as well as the branding and marketing of the business. ICS simplifies regulatory requirements and provides training to help develop responsible staff members to understand and comply with developing medical cannabis commerce. Clients will become familiar with medical cannabis laws and Marijuana Enforcement Division (MED) regulations. A major factor of any strong compliance program is the ability to foresee, and then control changes affecting costs and overall risk within the industry.

Private Cannabis Club Services
Colorado and Washington have both legalized recreational marijuana for adult use. This has opened the door for Colorado and Washington businesses to create private cannabis clubs for residents, and out-of-state tourists to partake in the consumption of marijuana products. ICS helps ensure that these private clubs are 100% compliant with regulations, operate appropriately, and help encourage responsible practices.

Industrial Hemp Services
We know that because of the changing landscape of the marijuana industry, industrial hemp is beginning to grow within Colorado. Through our knowledge of the industry, ICS’s services help hemp businesses develop the resources needed to grow a successful business. ICS helps ensure that regulations are understood and that businesses are operating according to reliable protocols producing significant profit margins.

Commercial Property
ICS plans to redefine the commercial real estate industry by elevating property value through enhancements specifically geared toward the marijuana industry. The Company has already identified multiple commercial real estate properties that meet all the requirements needed to lease to prospective marijuana businesses.

Because of the current demand for commercial space, and competitive nature of the recreational marijuana business, ICS cannot disclose the exact locations of each property it is pursuing. Please contact the Company if you would like to inquire about the specific details of each prospective property. Upon verification of Accredited Investor status, we will provide our entire real estate package for review.



Industry
Legalized marijuana is one of the fastest-growing markets in the United States, and it’s growing at a rate poised to outpace the expansion of the global smartphone market, according to a report published by The Huffington Post. In their report, an estimated $1.43 billion worth of legal marijuana was sold in 2013, and also predicts that figure to grow by 64 percent, to $2.34 billion in 2014. There are currently 20 states and the District of Columbia that have enacted laws to legalize medical marijuana, with California paving the way in 1996.
http://www.integratedcannabissolutions.com/industry.html




Quote:$IGPK - Integrated Parking Solutions, Inc. Announces Company Name Change to Integrated Cannabis Solutions, Inc.
BALTIMORE, MD, Apr 28, 2014 (Marketwired via COMTEX) -- Integrated Parking Solutions, Inc. (PINKSHEETS: IGPK) announced that it has changed its name to Integrated Cannabis Solutions, Inc. to better reflect its business strategy of offering services geared towards reducing the risk, cost and complexity for responsible cannabis businesses during this monumental process of transitioning from prohibition to regulation.

The Company provides consulting on compliance, operations, and business management, as well as the branding and marketing of the business. ICS simplifies regulatory requirements and provides training to help develop responsible staff members to understand and comply with developing medical cannabis commerce. Clients will become familiar with medical cannabis laws and Marijuana Enforcement Division (MED) regulations. A major factor of any strong compliance program is the ability to foresee, and then control changes affecting costs and overall risk within the industry.

For more information on Integrated Cannabis Solutions, please visit www.integratedcannabissolutions.com
http://www.stockwatch.com/News/Item.aspx?bid=...GPK®ion%3DU



IGPK Key Company Management
Alphonse Rojas,
the Company’s CEO and CFO




IGPK Contact Info
Integrated Cannabis Solutions - OTC: IGPK
Tel: 702-324-3984
info@integratedcannabissolutions.com
400 E. Pratt Street
8th floor
Baltimore, MD 21202

Website: http://www.integratedcannabissolutions.com/

IGPK SEC Filings
http://www.otcmarkets.com/stock/IGPK/filings

IGPK Headlines
http://finance.yahoo.com/q/h?s=IGPK+Headlines

Investigate more about IGPK @ http://www.otcmarkets.com/stock/IGPK/quote for more due diligence.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading